<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for HB 3720         </title>
<shortdesc>DRUG AND SHARPS WASTE PROGRAM</shortdesc>
<sponsor>
<sponsorhead1>House Sponsors</sponsorhead1><sponsors>Rep. C.D. Davidsmeyer</sponsors>
</sponsor>
<lastaction>
<statusdate>1/10/2023</statusdate><chamber>House</chamber><action>Session Sine Die</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>New Act</reference><aliasreference></aliasreference><SynopsisText>   Creates the Drug and Sharps Waste Stewardship Act. Directs the Environmental Protection Agency to administer a drug and sharps waste stewardship program. Provides that the State Board of Pharmacy is to guide and advise the Agency in its administration of the program. Requires covered entities to provide lists of covered and not covered products to the State Board and to implement stewardship plans. Requires stewardship plans to be submitted to the Agency for review and acceptance. Requires that all counties have at least one collection site for unused drugs and sharps per 50,000 people and no fewer than 5 collection sites. Requires counties that do not have the necessary number of collection sites to establish a mail-back program, an alternative collection program for covered products, or both. Imposes an administrative fee on covered entities. Provides penalties for covered entities that fail to comply with the provisions of the Act. Creates the Drug and Sharps Stewardship Fund and the Pharmaceutical and Sharps Stewardship Penalty Account. Directs the Agency to post lists of compliant covered entities on its website. Exempts stewardship programs already in existence under local ordinances at the time the Act takes effect from the Act's provisions, but provides that those entities with programs that are not within the Act's purview are not eligible to receive any monetary support from the Fund or the Account. Exempts confidential proprietary information from public disclosure by the Agency.</SynopsisText></synopsis>
<actions>
<statusdate>2/19/2021</statusdate><chamber>House</chamber><action>Filed with the Clerk by Rep. C.D. Davidsmeyer</action>
<statusdate>2/22/2021</statusdate><chamber>House</chamber><action>First Reading</action>
<statusdate>2/22/2021</statusdate><chamber>House</chamber><action>Referred to Rules Committee</action>
<statusdate>3/16/2021</statusdate><chamber>House</chamber><action>Assigned to Prescription Drug Affordability &amp; Accessibility Committee</action>
<statusdate>3/27/2021</statusdate><chamber>House</chamber><action>Rule 19(a) / Re-referred to Rules Committee</action>
<statusdate>1/10/2023</statusdate><chamber>House</chamber><action>Session Sine Die</action>
</actions>
</xml>

